ABBV vs CON · P/E 81, rev $61.16B vs P/E 18, rev $1.90B
AbbVie Inc (ABBV) versus Concentra Group Holdings Parent, Inc. (CON) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Concentra Group Holdings Parent, Inc. (CON) is a medical care facilities company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CON revenue for 2024-12-31 was $1.90B. Net income was $171.9M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. CON currently screens at market cap $3.18B and trailing P/E 17.9.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CON currently screens at market cap $3.18B and trailing P/E 17.9.
Not investment advice. Open the ABBV and CON stock pages for the full models.
Not investment advice.